Search the Archive

Cancer / Interleukin-2 #100369

ABC Evening News for Friday, Dec 12, 1986
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Peter Jennings) Report introduced.

(NYC: George Strait) Dr. Charles Moertel, in "Journal of American Med. Association", reported warning of side effects and costs of interleukin-2 (Illinois-2), hailed last yr. as breakthrough in cancer treatment; details given, scenes shown. [December 1985, PATIENT - is hopeful now.] Illinois-2 explained, illustrated. [Jean GROTBERG - recalls optimism of late husband.] Husband said dying from interleukin-2's toxicity. Related statistics outlined on screen. [Shannon SYLVESTER - describes her experience on drug.] Moertel's findings outlined. Response of Dr. Steven Rosenberg, Illinois-2 developer, mentioned. [Dr. Vincent DEVITA - defs. proceeding with tests.]

Jennings, Peter;
Strait, George

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.